Search

Your search keyword '"Giansily‐Blaizot, Muriel"' showing total 44 results

Search Constraints

Start Over You searched for: Author "Giansily‐Blaizot, Muriel" Remove constraint Author: "Giansily‐Blaizot, Muriel" Database Unpaywall Remove constraint Database: Unpaywall
44 results on '"Giansily‐Blaizot, Muriel"'

Search Results

2. Surgery in rare bleeding disorders: the prospective MARACHI study

4. Homozygosity for the hyperunstable hemoglobin variant Hb Agrinio (HBA2:c.89T>C) leads to severe antenatal anemia: Eight new cases in three families

5. APOLD1 loss causes endothelial dysfunction involving cell junctions, cytoskeletal architecture, and Weibel-Palade bodies, while disrupting hemostasis

8. Increased incidence of germline PIEZO1 mutations in individuals with idiopathic erythrocytosis

9. The Clinical Severity of Alpha-2 Globin Gene Variants: Homozygosity for Hb Agrinio (HBA2: c.89T>C) Leads to Severe Antenatal Anemia, about 8 Cases in 3 Families

10. The EAHAD blood coagulation factor VII variant database

17. Inherited or acquired modifiers of iron status may dramatically affect the phenotype in dehydrated hereditary stomatocytosis

20. Prospective Evaluation of Bleeding Incidence in Fibrinogen Deficiency (PRO-RBDD Study)

21. Inherited and Acquired Modifiers of Iron Status May Dramatically Affect the Phenotypic Expression of Dehydrated Hereditary Stomatocytosis

22. Isotypic analysis of antibodies against activated Factor VII in patients with Factor VII deficiency using the x-MAP technology

23. The role of genetic factors in patients with hepatocellular carcinoma and iron overload – a prospective series of 234 patients

29. Coagulation Factor Activity Level and Clinical Bleeding Severity in Rare Bleeding Disorders: Results From the European Network of Rare Bleeding Disorders (EN-RBD),

30. At Disease Presentation, Severity of the Bleeding Symptom Predicts the Following Bleeds in Patients with FVII Deficiency

31. Replacement Therapy for Minor Surgery and Invasive Procedures in Factor VII Deficiency: The STER Experience

32. Prophylaxis In Congenital Factor VII Deficiency, Indications, Efficacy and Safety: Results of the STER

34. The Southern French Registry of Genetic Hemochromatosis, a Tool for Determination of Clinical Prevalence and Genotype Penetrance of the Disorder.

Catalog

Books, media, physical & digital resources